NAPE-PLD: the healthy intersection of N-acylethanolamines and bile acids in physiology and diseases
Authors:
- 15 August 2026
- journal article
- review article
- Published by Springer Nature in Pflügers Archiv - European Journal of Physiology
- Vol. 478 (9) , 74
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- The endocannabinoidomes: Pharmacological redundancy and promiscuity, and multi-kingdom variety of sources and molecular targetsPharmacological Reviews, 2025
- NAPE-PLD is target of thiazide diureticsCell Chemical Biology, 2025
- Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targetsSignal Transduction and Targeted Therapy, 2024
- Bile acids and neurological diseasePharmacology & Therapeutics, 2022
- Parallels between the Developing Vascular and Neural Systems: Signaling Pathways and Future Perspectives for Regenerative MedicineAdvanced Science, 2021
- Hypothalamic bile acid-TGR5 signaling protects from obesityCell Metabolism, 2021
- Disorders affecting vitamin B6 metabolismJournal of Inherited Metabolic Disease, 2019
- Structure of Human N -Acylphosphatidylethanolamine-Hydrolyzing Phospholipase D: Regulation of Fatty Acid Ethanolamide Biosynthesis by Bile AcidsStructure, 2015
- A Common Haplotype in NAPEPLD Is Associated With Severe Obesity in a Norwegian Population‐Based Cohort (the HUNT Study)Obesity, 2011
- Role of cholesterol and lipid organization in diseaseNature, 2005